ZFIN Fish: igfn1.1^nkgsaizGFFD109AGt; zf3262Tg; zf415Tg

ZFIN ID: ZDB-FISH-210901-2

ZFIN ID: ZDB-FISH-210901-2

Fish name:	igfn1.1^{nkgsaizGFFD109AGt}; zf3262Tg; zf415Tg
Genotype:	igfn1.1^{nkgsaizGFFD109AGt}; zf3262Tg; zf415Tg
Targeting Reagent:	none

HUMAN DISEASE MODELED by igfn1.1^{nkgsaizGFFD109AGt}; zf3262Tg; zf415Tg
No data available

GENE EXPRESSION
Gene expression in igfn1.1^{nkgsaizGFFD109AGt}; zf3262Tg; zf415Tg

RNA expression No data available

Protein expression No data available

Reporter gene expression

Expressed Gene	Structure	Conditions	Figures
GCaMP	brain trunk musculature	standard conditions	Fig. 3 from Leung et al., 2019
GFP	heart	standard conditions	Fig. 3 from Leung et al., 2019

PHENOTYPE
Phenotype in igfn1.1^{nkgsaizGFFD109AGt}; zf3262Tg; zf415Tg

Phenotype	Conditions	Figures
dorsal telencephalon neuronal action potential decreased frequency, abnormal	chemical treatment by environment: mepyramine	Fig. 3 from Leung et al., 2019
dorsal telencephalon neuronal action potential synchronous, abnormal	chemical treatment by environment: mepyramine	Fig. 3 from Leung et al., 2019
eye movement quality, abnormal	chemical treatment by environment: carbachol	Fig. 3 from Leung et al., 2019
eye movement quality, abnormal	chemical treatment by environment: mepyramine	Fig. 3 from Leung et al., 2019
heart contraction decreased occurrence, abnormal	chemical treatment by environment: mepyramine	Fig. 3 from Leung et al., 2019
heart contraction decreased occurrence, abnormal	chemical treatment by environment: carbachol	Fig. 3 from Leung et al., 2019
muscle contraction decreased occurrence, abnormal	chemical treatment by environment: carbachol	Fig. 3 from Leung et al., 2019
muscle contraction decreased occurrence, abnormal	chemical treatment by environment: mepyramine	Fig. 3 from Leung et al., 2019

CITATIONS (1)